Results from SPOTLIGHT, a Phase 1b/2a Dose Escalation Study of the anti-c-Kit Briquilimab Antibody in Adults with Inducible Urticaria (CIndU) Who Remain Symptomatic Despite H-1 Antihistamine Treatment

Journal of Allergy and Clinical Immunology 2026 Open access

Read full text

Authors: Sravan Jaggumantri, Martin Metz, Edwin Tucker, Patricia Carlos, Selma Nakhjavani, Wendy W. Pang, Daniel C. Adelman, Melba Muñoz

DOI: 10.1016/j.jaci.2025.12.080

Cited by: 0

Fields of Study & Subjects

Urticaria and Related Conditions Mast cells and histamine Eosinophilic Disorders and Syndromes